Methylated SYDE1 was demonstrated to be significantly associated with the relapse-free survival of patients with breast cancer (26) However, there are currently no studies regarding the implications of SLURP1 and SYDE2 in cervical cancer. Here, SLURP1 is linked to breast carcinoma.